Apogee Therapeutics, Inc. (APGE)
NASDAQ: APGE · Real-Time Price · USD
85.37
-1.10 (-1.27%)
At close: Apr 28, 2026, 4:00 PM EDT
85.65
+0.28 (0.33%)
Pre-market: Apr 29, 2026, 5:34 AM EDT
Apogee Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Net Income | -255.84 | -182.15 | -83.99 | -43.4 |
| Depreciation & Amortization | 1.42 | 0.19 | - | - |
| Loss (Gain) From Sale of Investments | -7.5 | -12.24 | -3.07 | - |
| Stock-Based Compensation | 46.28 | 23.33 | 6.1 | 2.34 |
| Other Operating Activities | 3.68 | 1.69 | 0.09 | 12.44 |
| Change in Accounts Payable | 0.15 | -1.07 | 1.61 | 0.46 |
| Change in Other Net Operating Assets | -15.63 | -0.93 | 4.49 | 10.25 |
| Operating Cash Flow | -227.45 | -171.17 | -74.76 | -17.92 |
| Capital Expenditures | -5.15 | -1.15 | -0.17 | - |
| Investment in Securities | -174.43 | -299.31 | -273.74 | - |
| Investing Cash Flow | -179.57 | -300.46 | -273.91 | - |
| Issuance of Common Stock | 396.49 | 495.11 | 315.39 | - |
| Other Financing Activities | - | - | - | -0.75 |
| Financing Cash Flow | 396.49 | 495.11 | 315.39 | 183.62 |
| Net Cash Flow | -10.53 | 23.47 | -33.28 | 165.7 |
| Free Cash Flow | -232.6 | -172.33 | -74.93 | -17.92 |
| Free Cash Flow Per Share | -3.83 | -3.12 | -3.00 | -7.28 |
| Levered Free Cash Flow | -138.98 | -113.42 | -45.5 | - |
| Unlevered Free Cash Flow | -138.98 | -113.42 | -45.5 | - |
| Change in Working Capital | -15.48 | -2 | 6.11 | 10.71 |
Source: S&P Capital IQ. Standard template.
Financial Sources.